Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, a doctor can prescribe Mounjaro for weight loss in the UK — but only after a formal clinical assessment confirms you meet the licensed eligibility criteria. Mounjaro (tirzepatide) is a Prescription-Only Medicine, so no route exists that bypasses that assessment, whether through your GP or a regulated online service. What changes between routes is how quickly that assessment can happen, who carries it out, and whether the NHS or private funding covers it. The NICE technology appraisal for tirzepatide (TA1026) sets out the clinical framework that shapes those decisions across the UK.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The starting point is the medicine's UK licence, which permits tirzepatide for weight management in adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea. That licence is the floor, it tells a prescriber what the medicine is authorised to treat. The NICE appraisal (TA1026) then sets a higher bar for NHS use: a BMI of 35 or more, with at least one qualifying comorbidity. For people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, those thresholds are each reduced by 2.5 kg/m².
SURMOUNT-1 (the phase 3 trial that supported the licence) showed an average body-weight reduction of around 20 to 21 percent at the 15mg dose over 72 weeks, in adults without diabetes. That evidence base is what persuaded NICE to recommend it. Any doctor prescribing outside those parameters would need to justify the decision clinically, which is why the consultation process matters regardless of the route you take. Who is actually licensed to issue a Mounjaro prescription is a separate but related question worth understanding.
The short version: the medicine is licensed; a prescriber who has assessed you properly and confirms you meet the criteria can legally write that prescription. The question is really which prescriber, through which route.
From 1 April 2026, some GP practices in England gained the ability to prescribe Mounjaro under the updated GP contract (QOF 2026/27). That is a meaningful change, but participation is optional, so whether your surgery offers it depends on your practice, your local Integrated Care Board, and which NHS cohort you fall into. The current NHS eligibility cohort requires a BMI of 40 or above and four or more of five specified conditions (hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease or type 2 diabetes). A second cohort (BMI 35 to 39.9 with four or more conditions) activated in June 2026.
Even if your GP does participate, every NHS patient must also be enrolled in wraparound diet and activity support; having the right numbers on paper does not automatically mean treatment starts immediately. How NHS prescribing of Mounjaro works in practice covers the full phased rollout in more detail. If your BMI or condition profile places you outside those NHS cohorts for now, a private clinical assessment is the realistic alternative. If you are unsure where your GP stands, whether a GP can prescribe Mounjaro and under what circumstances explains the rules in full.
Wales, Scotland and Northern Ireland have their own access frameworks. Criteria differ, so if you are not in England it is worth checking what applies to you locally before making assumptions based on NHS England guidance.
Private prescribing of Mounjaro operates under the same medicine licence but is not constrained by the NICE NHS thresholds. A GPhC-registered Independent Prescriber assesses your information (BMI, health history, current medicines) and decides whether treatment is clinically appropriate. At nume, that review happens the same working day; a named prescriber reads your consultation, not software. Order before noon on a weekday and, once approved as clinically suitable, your treatment is dispatched the same day and delivered free the next working day by DPD, in plain unbranded packaging. That 12pm cut-off matters if you are trying to avoid an extra day's wait.
Identity and weight are verified as part of every consultation, and your GP is notified in line with GPhC guidance. There are no subscriptions. Every repeat order goes through a fresh clinical review. How we work at nume sets out the full process, and you can verify our GPhC registration at any point, our premises number is 9012878, checkable directly on the GPhC pharmacy register.
If you want to understand the cost side before starting, what Mounjaro costs through a private prescription explains what a transparent private price typically covers and what to look out for when comparing providers.
A few practical things are worth having clear before you raise Mounjaro with your GP or start an online consultation. First, your approximate BMI, the NHS tool at nhs.uk takes 30 seconds and gives you the number a prescriber will be working from. Second, any diagnosed conditions that might qualify as weight-related comorbidities: these include prediabetes, type 2 diabetes, high cholesterol and hypertension among others. Third, your current medications, some interactions require prescriber discussion, particularly oral contraceptives during the first weeks of tirzepatide treatment, where an additional non-oral method is advised.
Pregnancy, breastfeeding and plans to conceive in the near term are all reasons Mounjaro is not recommended; the prescriber will ask about these directly. Under-18s are outside the licensed age range. None of this is meant to discourage, it is meant to make the conversation with whichever prescriber you choose more productive. Getting Mounjaro through a doctor walks through what to expect at that appointment in more detail, and if you are specifically wondering whether a doctor can prescribe Mounjaro for weight loss in a private setting, that page covers the clinical and regulatory picture clearly. If you would prefer to explore your options online first, checking your eligibility with our prescribers is free and carries no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.